Alcoholic Liver Cirrhosis

The goal of this observational study is to learn about the long-term safety of Cellgram-LC in patients with alcoholic liver cirrhosis who previously received Cellgram-LC in the PMC-P-07 study. The main question it aims to answer is: \- Do adverse event of special interest (AESI) or liver transplantation occur during the 5 years after Cellgram-LC administration? Participants who previously received Cellgram-LC in the PMC-P-07 study and voluntarily consent to participate in this long-term follow-up study will be followed for 5 years after Cellgram-LC administration through telephone visits to collect information on AESI and liver transplantation.